Abstract:Objective The purpose of this work is to investigate how the Rho family of GTPases A (RhoA) mediates the pathogenesis of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). Methods The expression of RhoA in the synovial tissues of RA and Healthy people (Control) was detected using immunohistochemistry methods. The expression of RhoA and hypoxia-inducible factor-1α (HIF-1α) is inhibited by small interfering RNAs (siRNAs). The inhibition effect on RA-FLS migration was further investigated. The protein expression level of HIF-1α, RhoA, focal adhesion kinase (FAK), and myosin light chain (MLC) was also analysed using western blotting (WB). DBA1 mice were immunised with the mixture of bovine type II collagen and Freund's adjuvant to establish collagen induced arthritis (CIA) mouse model. Lip-siRhoA is administered through joint injection every two days. Micro-computed tomography (micro-CT) was used to detect mouse ankle joint destruction and evaluate the bone loss of the periarticular side. Destruction of the ankle articular cartilage was tested by histology. Expressions of P-RhoA, P-FAK and P-MLC in the ankle joint was detected by immunohistochemistry assay. Results The expression level of RhoA in the synovial tissues of RA patients was significantly higher than that in control group. Hypoxia was able to up-regulate the expression of RhoA. Whereas, HIF-1α siRNA (siHIF-1α) could down-regulate the expression of RhoA. Additionally, both of siHIF-1α and RhoA siRNA (siRhoA) delivered by liposome (Lip-siHIF-1α and Lip-siRhoA) were found to suppress FAK and MLC phosphorylation in vitro. In CIA mouse model, Lip-siRhoA was demonstrated to ameliorate the destruction of ankle joint and reduce the severity of ankle joint cartilage damage by micro-CT and histological staining, respectively. Therefore, inhibition of FLS cell migration can protect articular bone from destruction. Furthermore, the expression of P-RhoA, P-FAK and P-MLC was evaluated and found to be down-regulated by Lip-siRhoA in vivo. Conclusion The results demonstrated that under hypoxic environment, HIF-1α dependent RhoA pathway played an important role on cytoskeleton remodelling and RA-FLS migration. Through down-regulating RhoA expression, it could effectively treat RA in vitro and in vivo. The translational potential of this article Our study provides new evidence for the potential clinical application of RhoA as a candidate for the treatment of RA.

Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis

[Role of Hypoxia-Inducible Factor in the Pathogenesis of Rheumatoid Arthritis].

Hypoxia-Inducible Factor Is Critical for Pathogenesis and Regulation of Immune Cell Functions in Rheumatoid Arthritis

Hypoxia And Hypoxia-Inducible Factor-1 Alpha Provoke Toll-Like Receptor Signalling-Induced Inflammation In Rheumatoid Arthritis

Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis.

Hypoxia-inducible Factor-1Α and Interleukin 33 Form a Regulatory Circuit to Perpetuate the Inflammation in Rheumatoid Arthritis.

Targeted Drug Delivery Strategies for the Treatment of Rheumatoid Arthritis

HIF-1α dependent RhoA as a novel therapeutic target to regulate rheumatoid arthritis fibroblast-like synoviocytes migration in vitro and in vivo

Hypoxia Induces Production of Citrullinated Proteins in Human Fibroblast-Like Synoviocytes Through Regulating HIF1α.

Sphingosine-1-phosphate: a Potential Therapeutic Target for Rheumatoid Arthritis

PI3 Kinase/akt/hif-1Α Pathway is Associated with Hypoxia-Induced Epithelial–mesenchymal Transition in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis

Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis

Increased Autophagy in Fibroblast-Like Synoviocytes Leads to Immune Enhancement Potential in Rheumatoid Arthritis

Hypoxia-inducible factor 1 in autoimmune diseases.

Hypoxia-inducible Factor-1 Regulates the Interleukin-6 Production by B Cells in Rheumatoid Arthritis

Discovery of novel diaryl substituted isoquinolin-1( 2H )-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis

HIF-1α expression in RA tissues and its correlation

HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications

HIF-1 in Osteoarthritis: from Pathogenesis to Therapeutic Implications

CD147 Induces Angiogenesis Through a Vascular Endothelial Growth Factor and Hypoxia-Inducible Transcription Factor 1Α-Mediated Pathway in Rheumatoid Arthritis.

Notch‐1 and Notch‐3 Mediate Hypoxia‐Induced Activation of Synovial Fibroblasts in Rheumatoid Arthritis